Choi, B.; Kim, E.-Y.; Kim, J.-E.; Oh, S.; Park, S.-O.; Kim, S.-M.; Choi, H.; Song, J.-K.; Chang, E.-J.
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification. Cells 2021, 10, 57.
https://doi.org/10.3390/cells10010057
AMA Style
Choi B, Kim E-Y, Kim J-E, Oh S, Park S-O, Kim S-M, Choi H, Song J-K, Chang E-J.
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification. Cells. 2021; 10(1):57.
https://doi.org/10.3390/cells10010057
Chicago/Turabian Style
Choi, Bongkun, Eun-Young Kim, Ji-Eun Kim, Soyoon Oh, Si-On Park, Sang-Min Kim, Hyuksu Choi, Jae-Kwan Song, and Eun-Ju Chang.
2021. "Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification" Cells 10, no. 1: 57.
https://doi.org/10.3390/cells10010057
APA Style
Choi, B., Kim, E.-Y., Kim, J.-E., Oh, S., Park, S.-O., Kim, S.-M., Choi, H., Song, J.-K., & Chang, E.-J.
(2021). Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification. Cells, 10(1), 57.
https://doi.org/10.3390/cells10010057